We surveyed the prescriptions from the Department of Dermatology in a city hospital to determine the status of the use of admixtures of corticosteroid ointments with other ointments. Thirty percent of the prescriptions of topical ointment therapy for outpatients of the Department were for admixture ointments. They were prescribed for patients aged 2 months to over 90 years. The mixing ratios of corticosteroid ointments with other ointments were 1：1 to 5：3. One-toone dilution was most frequently used. Corticosteroid ointments classiˆed into strongest, very strong, strong and medium groups were used for admixtures. We studied the eŠect of admixture ointments on carrageenan-induced edema in rat hind paws to assess the anti-in‰ammatory activity of these admixtures. Dermovate TM , its 1：3-diluted preparation with white petrolatum and 1：1-diluted preparation of Lidomex TM with white petrolatum exerted signiˆcant anti-in‰amma-tory activity (p＜0.05, compared with white petrolatum). These results suggest that the admixtures of diŠerent corticosteroid ointments have diŠerent anti-in‰ammatory activities. When admixture preparations are used, the properties of the corticosteroid and other ointments should be taken into account individually.
INTRODUCTION
Commercially available topical corticosteroid ointments and/or creams (corticosteroid ointments) are well recognized as theˆrst line for treatment of various in‰ammatory conditions of the skin such as atopic dermatitis. Although corticosteroid ointments are eŠective when applied alone, the dilution or mixing of corticosteroid ointments is a common practice in our country because of the expected improvement of compliance and reduction of the adverse eŠects of the corticosteroid. 1) However, the practical status of mixing of corticosteroid and other ointments still remains unclear.
The pharmaceutical stability of the corticosteroid in the admixtures, permeability of the corticosteroid through the skin, and vasoconstriction activity of admixtures of corticosteroid ointments have been studied. [2] [3] [4] However, there have been no reports on the anti-in‰ammatory activity of admixtures of corticoid ointments.
To determine the status of the use of mixtures of these ointments, we surveyed the current state of mixing of commercially available corticosteroid ointments with other ointments based on dermatological prescriptions in a city hospital. We also studied the eŠect of admixtures of corticoid ointments and other ointments on carrageenaninduced edema in rat hind paws to determine the in vivo anti-in‰ammatory eŠects of these admixtures.
MATERIALS AND METHODS

Survey of Mixing of Corticosteroid Ointments with Other Ointments with respect to Dermatological Prescriptions in a City Hospital
We surveyed the number of prescriptions for ointments containing mixtures of corticosteroid and other ointments for both in-patients and out-patients in the Department of Dermatology, St. Luke's Hospital (Tokyo, Japan). The period of the survey was 6 months from May to October 2001. The surveyed items in the prescriptions were age of the patient, kind of corticosteroid ointment used for admixture preparation, kind of other ointment used for admixture preparation, frequency of the admixture use, and mixing ratio of corticosteroid and other ointments. l-Carrageenan was purchased from Wako Pure Chemical Industries Inc. (Osaka, Japan).
Preparation of Admixture Ointments for Animal Experiments
Dermovate TM and Lidomex TM corticosteroid ointments were selected for use based on the results of the survey of prescriptions. Corticosteroid and other ointments were mixed at ratios that were decided based on the results of the survey of the prescriptions ( see``Results'').
Anti-in‰ammatory EŠect of the Admixtures of Corticosteroid Ointments on Carrageenan-induced Edema in Rat Hind Paws
After initial measurement of the hind-paw volume using a water plethysmometer (TK101P, UNICOM Inc. Chiba, Japan), 0.1 g of ointment was applied to the right hind paw, and the paw was wrapped with cotton and a latex sac to avoid the removal of ointment by grooming. The left hind paw was wrapped only with cotton and a latex sac. After 4 hours, 0.1 mL of suspension containing 1％ l-carrageenan in saline was injected subcutaneously in both the left and right hind paws of rats. Since our preliminary experiments revealed that the edema in rat hind paws reached a peak 4 hours after the subcutaneous injection of carrageenan (data not shown), we measured the volume of the rat hind paw 4 hours after the carrageenan injection.
The rate of edema suppression was calculated from the volumes of rat hind paws 4 hours after carrageenan injection by using the following equations: edema rate＝hind paw volume 4 hours after carrageenan injection/initial hind paw volume edema suppression rate＝1-(edema rate of the ointment-applied paw/edema rate of the control paw)
For statistical analysis test, Turkey's honesty signiˆcant diŠerence test (SPSS 10.0 J) was used. A signiˆcant level lower than 5％ was deˆned as signiˆcant.
RESULTS
Survey of Mixing of Corticosteroid Ointments with Other Ointments with respect to Prescriptions in the Department of DermatologyNumber of Prescriptions of Topical Ointments and Admixtures of Corticosteroid Ointment with Other Ointments
During the period of the survey, the numbers of prescriptions for topical ointments were 1145 for outpatients and 1392 for inpatients. Among these prescriptions, 219 prescriptions for outpatients (39％) and 85 prescriptions for inpatients (6％) were for admixtures of corticosteroid ointments with other ointments. The age of the patients was distributed from 2 months to 96 years, with a median of 20 years.
Corticosteroid Ointments in Admixture Prescriptions
As shown in Table 1 , nine corticosteroid ointments were prescribed for admixture preparations. These corticosteroid ointments were classiˆed into a strongest group, very strong group, strong group, and medium group according to our classiˆca-tion system for corticosteroid ointments.
Myster TM ointment and Rinderon VG TM ointment were used most frequently, and 60％ of the ointments in the mixed preparations were in the very strong group.
Other Ointments in Admixture Prescriptions Nine ointments other than corticosteroid ones were prescribed for the mixing preparations ( Table 2) . Keratinamin TM ointment, which is a urea ointment, zinc oxide ointment, and Hirudoidosoft TM were frequently used. White petrolatum was used for admixture preparations as a basal material without pharmacological action.
Mixing ratio of Corticosteroid Ointment and Other Ointment
The mixing ratio of corticosteroid ointments and other ointments ranged from 1：1 to 5：3 (weight/weight ratio). The ratio most frequently prescribed was 1：1 (94％), followed by 1：3 ( Table  3) .
Anti-in‰ammatory EŠect of Admixture Ointments of Corticosteroid and Other Ointments
Since corticosteroid ointments of the strongest group and the strong group were among those prescribed for the admixture preparations in the survey, Dermovate TM White petrolatum, which exerted no edema suppressive eŠects, was used for mixing with corticosteroid ointments. Since 1：1 dilutions were most frequently used in the clinical prescriptions, a mixing ratio of 1：1 was used. A 1：3-dilution was also used for the admixture preparations.
The admixture of Dermovate TM with white petrolatum (1：3) showed almost the same edema suppressive activity as Dermovate TM itself ( p＜0.05), but the 1：1 admixture preparation of these ointments had only weak suppressive activity. The admixture of Lidomex TM and white petrolatum (1：1) signiˆcantly suppressed ( p ＜ 0.05 ) . The edema whereas Lidomex TM itself and 1：3-diluted Lidomex TM with white petrolatum had weaker edema suppressive activity than 1：1-diluted preparation (Fig. 1) .
DISCUSSION
Admixture preparations of corticosteroid ointments with other ointments are frequently prescribed by dermatologists in our country. Eto et al. reported that 85％ of dermatologists prescribed admixture preparations of corticosteroid ointments to improve compliance of patients, to reduce adverse reactions and to obtain possible additive or synergistic eŠects. 1) In the present survey, it was also shown that admixture preparations were widely prescribed for patients with a wide range of age, i.e., infants to elderly patients older than 90. Nine corticosteroid ointments (ranging from a strongest group to a medium group) were prescribed for the admixture preparations (Table 1). Nine ointments other than corticosteroid ointments were used for preparing the admixtures with corticosteroid ointments ( Table 2) . Keratinamin TM With regard to admixture preparations, there have been many reports showing changes in the appearance or stability of the active component. However, there have been few reports on the eŠect of mixing these ointments on the clinical eŠect and/or adverse eŠects. [3] [4] [5] [6] Guin et al. reported that the vasoconstrictive eŠect of a corticosteroid ointment containing ‰uocinolone acetonide did not decrease in dilutions with white petrolatum, and showed augmentation in some cases. 3) For commercially available corticosteroid ointments, the base materials and concentrations of active components have been decided based on the properties of the active agents. In the development of these ointments, the eŠect of mixing and/or dilution with other ointments has not been studied in most cases. Thus, it is possible that the physicochemical properties of the base material might be aŠected by mixing ointments, and that this might lead to the eventual acceleration of the release of the active component. 3, 7) In this study, our survey provided information about the dilutions of corticosteroid ointments with other ointments actually used clinically in the dermatologicalˆeld. However, the precise purpose and mechanisms of these admixtures remain unclear. We studied the anti-in‰ammatory eŠect of admixtures of two corticosteroid ointments, i.e., Dermovate TM and Lidomex TM , with white petrolatum. Dermovate TM itself and the 1：3-diluted ointment caused signiˆcant suppression of carrageenan-induced edema, which is an anti-in‰ammatory eŠect, but the 1：1-diluted ointment had weaker activity (Fig. 1) . Furthermore, the 1：1-diluted Lidomex TM ointment had stronger anti-in‰ammatory activity than Lidomex TM itself or the 1：3-diluted ointment (Fig. 1) .
These results suggest that the anti-in‰ammatory activities of admixtures of corticosteroid ointments diŠer from each other in a manner that appears to depend on the corticosteroid ointment.
In this study, we found that admixtures or dilutions of corticosteroid ointment with other ointments are frequently prescribed in the dermatologicalˆeld. We suggest that some admixtures or diluted ointments might have good anti-in‰ammatory activity with weaker adverse eŠects. Dermatologists should know the characteristics of each corticosteroid ointment in order to decide whether to prescribe the ointment itself or a diluted admixture of ointments.
